BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 22156843)

  • 1. Overcoming limitations in the systems vaccinology approach: a pathway for accelerated HIV vaccine development.
    Zak DE; Aderem A
    Curr Opin HIV AIDS; 2012 Jan; 7(1):58-63. PubMed ID: 22156843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current world literature.
    Curr Opin HIV AIDS; 2012 Jan; 7(1):86-95. PubMed ID: 22156801
    [No Abstract]   [Full Text] [Related]  

  • 3. Systems biology in the development of HIV vaccines.
    Haddad EK; Pantaleo G
    Curr Opin HIV AIDS; 2012 Jan; 7(1):44-9. PubMed ID: 22156842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systems vaccinology: its promise and challenge for HIV vaccine development.
    Nakaya HI; Pulendran B
    Curr Opin HIV AIDS; 2012 Jan; 7(1):24-31. PubMed ID: 22156839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systems integration of innate and adaptive immunity.
    Zak DE; Aderem A
    Vaccine; 2015 Sep; 33(40):5241-8. PubMed ID: 26102534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV vaccine development at the turn of the 21st century.
    Girard MP; Plotkin SA
    Curr Opin HIV AIDS; 2012 Jan; 7(1):4-9. PubMed ID: 22156840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV vaccine development: Lessons from the past, informing the future.
    Bradac J; Dieffenbach CW
    IDrugs; 2009 Jul; 12(7):435-9. PubMed ID: 19579164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of primate models for AIDS.
    Haigwood NL
    AIDS Rev; 2004; 6(4):187-98. PubMed ID: 15700617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Innate gamma/delta T-cells during HIV infection: Terra relatively Incognita in novel vaccination strategies?
    Agrati C; D'Offizi G; Gougeon ML; Malkovsky M; Sacchi A; Casetti R; Bordoni V; Cimini E; Martini F
    AIDS Rev; 2011; 13(1):3-12. PubMed ID: 21412385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review.
    Girard MP; Osmanov S; Assossou OM; Kieny MP
    Vaccine; 2011 Aug; 29(37):6191-218. PubMed ID: 21718747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling immunity to HIV vaccines with systems biology.
    Andersen-Nissen E; Heit A; McElrath MJ
    Curr Opin HIV AIDS; 2012 Jan; 7(1):32-7. PubMed ID: 22134340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress towards an HIV vaccine based on recombinant bacillus Calmette-Guérin: failures and challenges.
    Joseph J; Saubi N; Pezzat E; Gatell JM
    Expert Rev Vaccines; 2006 Dec; 5(6):827-38. PubMed ID: 17184220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot study.
    Ferrantelli F; Maggiorella MT; Schiavoni I; Sernicola L; Olivieri E; Farcomeni S; Pavone-Cossut MR; Moretti S; Belli R; Collacchi B; Srivastava IK; Titti F; Cafaro A; Barnett SW; Ensoli B
    Vaccine; 2011 Apr; 29(16):2918-32. PubMed ID: 21338681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine models for HIV vaccination and challenge.
    Boberg A; Bråve A; Johansson S; Wahren B; Hinkula J; Rollman E
    Expert Rev Vaccines; 2008 Feb; 7(1):117-30. PubMed ID: 18251698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AIDS vaccine development: the long and winding road.
    Garber DA; Feinberg MB
    AIDS Rev; 2003; 5(3):131-9. PubMed ID: 14598562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systems approach to understanding vaccines.
    von Bubnoff A
    IAVI Rep; 2010; 14(4):16-20. PubMed ID: 20857649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A safe, effective and affordable HIV vaccine--an urgent global need.
    Joseph J; Etcheverry F; Alcami J; María GJ
    AIDS Rev; 2005; 7(3):131-8. PubMed ID: 16302460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of T cell immune responses induced by vectored HIV vaccines in non-human primates and humans.
    Bett AJ; Dubey SA; Mehrotra DV; Guan L; Long R; Anderson K; Collins K; Gaunt C; Fernandez R; Cole S; Meschino S; Tang A; Sun X; Gurunathan S; Tartaglia J; Robertson MN; Shiver JW; Casimiro DR
    Vaccine; 2010 Nov; 28(50):7881-9. PubMed ID: 20937317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on mucosal HIV vaccine vectors.
    Duerr A
    Curr Opin HIV AIDS; 2010 Sep; 5(5):397-403. PubMed ID: 20978380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.